Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
02/03/2000 | CA2338209A1 Biphenyl derivatives |
02/03/2000 | CA2337756A1 Libraries of polyhydroxamates and their analogs |
02/03/2000 | CA2337247A1 Isquinolines as urokinase inhibitors |
02/03/2000 | CA2335341A1 Peptide analogues of pacap |
02/03/2000 | CA2335340A1 Fsh and fsh variant formulations, products and methods |
02/02/2000 | EP0976398A2 Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
02/02/2000 | EP0975354A1 Ligand/lytic peptide compositions and methods of use |
02/02/2000 | EP0881891A4 Male contraceptive implant |
02/02/2000 | EP0767794B1 Phosphinic acid derivatives |
02/02/2000 | CN1243440A Dosage forms and method for ameliorating male erectile dysfunction |
02/01/2000 | US6020513 Dihydronaphthalene and naphthalene compounds, intermediates, formulations, and methods |
02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
02/01/2000 | US6020179 Nucleic acids encoding human tyrosine phosphatases |
02/01/2000 | US6020163 Lipocalin homolog |
02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
01/27/2000 | WO2000004150A1 Human presenilin-associated protein |
01/27/2000 | WO2000004013A1 Antagonists of gonadotropin releasing hormone |
01/27/2000 | WO2000003979A1 Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments |
01/27/2000 | WO2000003708A1 Analgesic use of podophyllotoxin for treating pain conditions in female genital organs |
01/27/2000 | WO2000003698A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
01/27/2000 | WO2000003678A2 Subcutaneous medroxyprogesterone acetate for contraception |
01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
01/27/2000 | WO1999063115A3 Use of cathepsin s in the diagnosis and treatment of endometriosis |
01/27/2000 | CA2337516A1 Transdermal patch and topical compositions comprising propylnorapomorphine |
01/27/2000 | CA2337407A1 Antagonists of gonadotropin releasing hormone |
01/27/2000 | CA2333467A1 Human presenilin-associated protein |
01/26/2000 | EP0974359A2 FSH and FSH variant formulations, products and methods |
01/26/2000 | EP0973819A1 Non-antigenic branched polymer conjugates |
01/26/2000 | EP0973801A1 GnRH ANTAGONISTS |
01/26/2000 | EP0973774A1 1,5-dihydro-pyrazolo 3,4-d]-pyrimidinone derivatives |
01/26/2000 | EP0973551A2 Polymeric conjugates polyvalently presenting an agent for therapy |
01/26/2000 | EP0973505A1 Aqueous pharmaceutical composition comprising an active ingredient which is highly insoluble in water |
01/26/2000 | EP0778834B1 Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
01/26/2000 | EP0758895B1 Sublingual dosage forms containing apomorphine for use in the treatment of erectile dysfunction |
01/26/2000 | EP0650484B1 Endothelin receptor antagonists |
01/26/2000 | CN1242215A Traditional Chinese medicine oral liquor for treating male infertility |
01/25/2000 | US6017964 Administering to a male patient droloxifene or it's derivatives know as an antiestrogenic agent |
01/25/2000 | US6017949 Controlling the fertility in a female mammal, terminating a pregnancy, controlling pathological conditions and disorders of the female reproductive system |
01/25/2000 | US6017945 Useful in the treatment of restenosis, renal failure and pulmonary hypertension |
01/25/2000 | US6017944 Treating a variety of sex-hormone related and other conditions in both men and women; preventing pregnancy, treating lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism, sleep disorders |
01/25/2000 | US6017531 An extracellular neutral protease and a stabilizer of glyceryl cocoate as a wound healing agent and for debriding necrotic tissue; storage stable enzyme activity at room temperature; burns; cutaneous ulcers; pressure necroses incisional, |
01/20/2000 | WO2000003015A2 Human transport protein homologs |
01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
01/20/2000 | WO2000002881A2 Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric g protein |
01/20/2000 | WO2000002851A1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them |
01/20/2000 | WO2000002850A2 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
01/20/2000 | WO2000002573A1 Natural composition and method for the treatment of sexual dysfunction |
01/20/2000 | WO2000002558A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
01/20/2000 | WO2000002554A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
01/20/2000 | WO2000002540A1 Plaster which contains steroids, and a method for the production and use thereof |
01/20/2000 | WO1999052544A3 Regulation of ovarian maturation and function using epidermal growth factor |
01/20/2000 | WO1999049037A3 Protein phosphatase-related molecules |
01/20/2000 | WO1999047642A3 Development of normal offspring from oocytes injected with freeze-dried spermatozoa |
01/20/2000 | DE19833786A1 New diphenyl-benzocycloheptene derivatives, are tissue-selective estrogens and antiestrogens useful e.g. for treating osteoporosis or hormone-dependent tumors or in hormone replacement therapy |
01/20/2000 | CA2337261A1 Use of prenyltransferase inhibitors for preparing a medicine for treating pathologies resulting from heterotrimeric g protein membrane fixation |
01/20/2000 | CA2336990A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
01/20/2000 | CA2332307A1 Human transport protein homologs |
01/19/2000 | EP0971950A2 Secreted proteins and polynucleotides encoding them |
01/19/2000 | EP0971917A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
01/19/2000 | EP0971899A1 Hexahydroindenopyridine compounds having antispermatogenic activity |
01/19/2000 | EP0971722A1 An aphrodisiac for application to the sexual organs |
01/19/2000 | EP0971694A1 Drug preparations for treating sexual dysfunction |
01/19/2000 | EP0971690A1 Antiinfective free intramammary veterinary composition |
01/19/2000 | CN1241426A Convalescence capsule for treating gonarrhea and its preparation process |
01/19/2000 | CN1241423A Preparation of medicine for functional metrorrhagia |
01/19/2000 | CN1048499C Process for preparing appropriate salt of 11 beta-aryl-4-estrene pharmaceutical composition |
01/19/2000 | CN1048484C A process for preparing a composition containing benzoheterocycles |
01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
01/18/2000 | US6015819 Administering adrenergic blocking agent; reduction of orthostatic fall in blood pressure side effect; fda orange book listed patent for silodosin |
01/18/2000 | US6015818 Quinoline derivatives as bradykinin agonists |
01/18/2000 | US6015805 Potent antiprogestational activity and are useful in the treatment of fibroids, endometriosis, cervical ripening prior to delivery, hormone replacement therapy and in the control of fertility. |
01/18/2000 | US6015685 Ancrod proteins, their preparation and use |
01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
01/13/2000 | WO2000001404A1 Compositions and methods for $i(in vitro) fertilization |
01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
01/13/2000 | WO2000001366A1 A method of administering liposomal encapsulated taxane |
01/13/2000 | WO1999051259A3 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
01/13/2000 | DE19830651A1 Steroidhaltiges Pflaster, Verfahren zu seiner Herstellung und Verwendung Steroid-containing patch, process for its preparation and use |
01/13/2000 | DE19830431A1 Sulfonylamino-carbonsäure-N-arylamide als Guanylatcyclase-Aktivatoren Sulfonylamino-carboxylic acid N-arylamides as guanylate cyclase activators |
01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
01/13/2000 | CA2333307A1 Compositions and methods for in vitro fertilization |
01/12/2000 | EP0970112A2 Novel human cytokine/steroid receptor protein |
01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
01/12/2000 | EP0970104A2 Steroid sulfamates, method for the production and use thereof |
01/12/2000 | EP0656781B1 Composition comprising fertilized shell eggs |
01/12/2000 | CN1240650A Compound metronidazole suppository |
01/12/2000 | CN1048159C Method for preparing pharmaceutical composition contg. imidazolyl-alkenoic acid |
01/11/2000 | US6013455 Polynucleotides which identify and encode protein kinase homologs, amino acid sequences encoding pkh; methods of pkh production with expression vectors; hybridizes under given conditions |
01/06/2000 | WO2000000610A2 Human signal peptide-containing proteins |
01/06/2000 | WO2000000604A1 Methods and compositions for modulating spermatogenesis |
01/06/2000 | WO2000000594A2 Human transferases |
01/06/2000 | WO2000000510A2 Growth factor modulators |
01/06/2000 | WO1999057270A3 Human receptor molecules |
01/06/2000 | WO1999051185A3 Human galactosyl transferases |
01/06/2000 | CA2331779A1 Methods and compositions for modulating spermatogenesis |
01/06/2000 | CA2331399A1 Thienopyridine compounds, their production and use |
01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
01/06/2000 | CA2330565A1 Growth factor modulators |